Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes

Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes

Aims: Combined CFTR modulator therapies have dramatically altered pulmonary outcomes in patients with cystic fibrosis (CF). Their impact on glucose metabolism requires further investigations. This study aims to evaluate insulin requirements after initiation of combined CFTR modulator therapy in pati...

Full description

Bibliographic Details
Main Authors: Fabian Lurquin, Sophie Gohy, Michel P. Hermans, Vanessa Preumont
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
Cystic fibrosis
Cystic fibrosis-related diabetes
CFTR modulators
Insulin therapy
HOMA
Online Access:http://www.sciencedirect.com/science/article/pii/S221462372300008X

Internet

http://www.sciencedirect.com/science/article/pii/S221462372300008X

Similar Items